Related Experiment Videos
Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach
Sundararajan Srikanth1, Prakash Deedwania
1Department of Medicine, VA Central California Health Care System/University Medical Center, University of California, San Francisco Program at Fresno, 2615 East Clinton Avenue, Fresno, CA 93703, USA.
Insights
Diabetic patients face high cardiovascular disease risks. Comprehensive risk reduction strategies, addressing multiple factors, are crucial for lowering these risks effectively.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetic patients have elevated risks for cardiovascular (CV) disease morbidity and mortality.
- Historically, treatment focused primarily on glycemic control.
- Emerging evidence highlights the importance of managing other CV risk factors.
Purpose of the Study:
- To evaluate the effectiveness of comprehensive risk-reduction strategies in diabetic patients.
- To emphasize the need for a multi-faceted approach beyond glycemic control.
- To provide evidence for individualized, aggressive intervention in high-risk diabetic patients.
Main Methods:
- Review of existing studies on CV risk reduction in diabetes.
- Analysis of data from trials incorporating aggressive control of blood pressure, hyperlipidemia, and antithrombotic therapy.
- Assessment of emerging data on multi-component risk-reduction strategies.
Main Results:
- Aggressive control of blood pressure, hyperlipidemia, and antithrombotic therapy show a 15% to 30% reduction in the relative risk (RR) of CV events.
- Absolute risk of CV events remains high in intervention groups due to incomplete risk-reduction strategies.
- Multi-component risk-reduction strategies show promise in reducing the absolute risk of CV events.
Conclusions:
- A comprehensive therapeutic strategy addressing multiple CV risk components is beneficial for diabetic patients.
- Individualized and aggressive intervention is recommended for high-risk diabetic patients.
- Further research is needed on the benefits, feasibility, and cost-effectiveness of multi-component therapies.
Abstract:
Diabetic patients are at increased risk of CV disease morbidity and mortality. In the past,treatment of diabetic patients largely focused on tight glycemic control. A number of studies,however, have shown that aggressive control of blood pressure and hyperlipidemia and the institution of antithrombotic therapy are beneficial in reducing the risk of CV events in the diabetic patient. Although in general these studies have shown a 15% to 30% reduction in the RR of CV events, the absolute risk of CV events remains high in the intervention group, probably because most of these trials have not incorporated a comprehensive risk-reduction strategy. Emerging data suggest that a therapeutic strategy using appropriate therapy to address multiple components of CV risks in diabetic patients is indeed beneficial in reducing the absolute risk of CV events. Although more data are needed to substantiate the benefits, feasibility, and cost effectiveness of such therapy, there is sufficient evidence for the clinician to provide an individualized approach and to consider aggressive intervention to minimize the predictable risk of CV events in the high-risk diabetic patient.
Related Concept Videos
01:26Atherosclerosis III: Management
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:27Diabetic Retinopathy
01:26Coronary Artery Disease IV: Preventive Measures
01:30Coronary Artery Disease I: Introduction
01:22Complications of Diabetes Mellitus